Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akari Therapeutics PLC (NASDAQ:AKTX)

16.46
Delayed Data
As of 4:00pm ET
 +1.21 / +7.93%
Today’s Change
6.22
Today|||52-Week Range
22.20
+133.81%
Year-to-Date

Today’s Trading

Previous close15.25
Today’s open15.50
Day’s range15.41 - 17.25
Volume495,504
Average volume (3 months)552,046
Market cap$179.6M
Dividend yield--
Data as of 4:00pm ET, 04/26/2017

Growth & Valuation

Earnings growth (last year)+60.20%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book5.21

Competitors

 Today’s
change
Today’s
% change
PTGXProtagonist Therapeu...+0.01+0.09%
ASTAsterias Biotherapeu...+0.30+8.00%
VBIVVBI Vaccines Inc-0.15-3.21%
FATEFate Therapeutics In...+0.02+0.42%
Data as of 4:00pm ET, 04/26/2017

Financials

Next reporting dateMay 31, 2017
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$0.00
Annual profit (last year)-$18.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO, Director, Head-Investor &
Media Relations
Gur A. Roshwalb
Chief Operating Officer &
Director
Clive Stuart Richardson
Corporate headquarters
London, Greater London

Forecasts


Search for Jobs